Cannabix Technologies Inc. (BLOZF)
USD 0.24
(0.42%)
USD 0.24
(0.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 2.96 Million CAD | 30.03% |
| 2023 | 2.27 Million CAD | -32.94% |
| 2022 | 3.39 Million CAD | -63.52% |
| 2021 | 9.3 Million CAD | 192.58% |
| 2020 | 3.18 Million CAD | -20.77% |
| 2019 | 4.01 Million CAD | 172.98% |
| 2018 | 1.47 Million CAD | -60.69% |
| 2017 | 3.74 Million CAD | 281.24% |
| 2016 | 981.72 Thousand CAD | -42.11% |
| 2015 | 1.69 Million CAD | 356.43% |
| 2014 | 371.55 Thousand CAD | 374.62% |
| 2013 | 78.28 Thousand CAD | -64.43% |
| 2012 | 220.07 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 1.21 Million CAD | 168.37% |
| 2024 Q1 | 607.68 Thousand CAD | 67.25% |
| 2024 Q2 | 984.15 Thousand CAD | 61.95% |
| 2024 Q3 | 451.54 Thousand CAD | -54.12% |
| 2024 FY | 3.14 Million CAD | 38.19% |
| 2023 Q1 | 578.76 Thousand CAD | -10.77% |
| 2023 FY | 2.27 Million CAD | -32.94% |
| 2023 Q4 | 363.33 Thousand CAD | -50.25% |
| 2023 Q2 | 605.21 Thousand CAD | 4.57% |
| 2023 Q3 | 730.33 Thousand CAD | 20.67% |
| 2022 Q3 | 1.59 Million CAD | 164.98% |
| 2022 Q1 | 544.69 Thousand CAD | -92.36% |
| 2022 FY | 3.39 Million CAD | -63.52% |
| 2022 Q4 | 648.65 Thousand CAD | -59.45% |
| 2022 Q2 | 603.61 Thousand CAD | 10.82% |
| 2021 FY | 9.3 Million CAD | 192.58% |
| 2021 Q3 | 7.18 Million CAD | 1379.89% |
| 2021 Q1 | 1.1 Million CAD | 62.84% |
| 2021 Q2 | 485.57 Thousand CAD | -56.25% |
| 2021 Q4 | 7.12 Million CAD | -0.8% |
| 2020 Q3 | 523.43 Thousand CAD | -63.6% |
| 2020 Q4 | 681.6 Thousand CAD | 30.22% |
| 2020 FY | 3.18 Million CAD | -20.77% |
| 2020 Q1 | 538.43 Thousand CAD | -40.49% |
| 2020 Q2 | 1.43 Million CAD | 167.06% |
| 2019 Q2 | 2.27 Million CAD | 635.74% |
| 2019 FY | 4.01 Million CAD | 172.98% |
| 2019 Q3 | 524.4 Thousand CAD | -76.98% |
| 2019 Q4 | 904.79 Thousand CAD | 72.54% |
| 2019 Q1 | 309.57 Thousand CAD | -35.14% |
| 2018 Q2 | 360.68 Thousand CAD | 21.58% |
| 2018 FY | 1.47 Million CAD | -60.69% |
| 2018 Q3 | 336.65 Thousand CAD | -6.66% |
| 2018 Q1 | 296.67 Thousand CAD | -75.67% |
| 2018 Q4 | 477.32 Thousand CAD | 41.79% |
| 2017 Q4 | 1.21 Million CAD | -18.67% |
| 2017 Q3 | 1.49 Million CAD | 557.64% |
| 2017 Q1 | 796.06 Thousand CAD | 108.74% |
| 2017 Q2 | 227.94 Thousand CAD | -71.37% |
| 2017 FY | 3.74 Million CAD | 281.24% |
| 2016 Q1 | 179.66 Thousand CAD | -72.36% |
| 2016 Q3 | 218.98 Thousand CAD | 8.56% |
| 2016 FY | 981.72 Thousand CAD | -42.11% |
| 2016 Q4 | 381.35 Thousand CAD | 74.15% |
| 2016 Q2 | 201.71 Thousand CAD | 12.27% |
| 2015 FY | 1.69 Million CAD | 356.43% |
| 2015 Q4 | 649.96 Thousand CAD | 138.06% |
| 2015 Q3 | 273.02 Thousand CAD | 43.67% |
| 2015 Q2 | 190.03 Thousand CAD | -71.17% |
| 2015 Q1 | 659.23 Thousand CAD | 272.25% |
| 2014 Q3 | 107.27 Thousand CAD | 58.31% |
| 2014 Q4 | 177.09 Thousand CAD | 65.08% |
| 2014 Q2 | 67.76 Thousand CAD | 249.06% |
| 2014 Q1 | 19.41 Thousand CAD | -66.14% |
| 2014 FY | 371.55 Thousand CAD | 374.62% |
| 2013 Q1 | 7965.00 CAD | 0.0% |
| 2013 FY | 78.28 Thousand CAD | -64.43% |
| 2013 Q4 | 57.33 Thousand CAD | 1141.1% |
| 2013 Q3 | 4620.00 CAD | -44.73% |
| 2013 Q2 | 8359.00 CAD | 4.95% |
| 2012 FY | 220.07 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AVITA Medical, Inc. | 80.77 Million USD | 96.334% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -321.283% |
| Össur hf. | 396.18 Million USD | 99.252% |
| QHSLab, Inc. | 961.65 Thousand USD | -207.972% |
| Wellstar International, Inc. | 1.79 Million USD | -65.021% |
| Össur hf. | 396.18 Million USD | 99.252% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | 43.595% |
| Aurora Spine Corporation | 8.65 Million USD | 65.791% |
| BrainsWay Ltd. | 28.01 Million USD | 89.43% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -299.853% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 91.178% |
| Vivos Inc. | 2.78 Million USD | -6.261% |
| Kelyniam Global, Inc. | 2.27 Million USD | -30.167% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -191.813% |
| Zecotek Photonics Inc. | 3.46 Million USD | 14.44% |
| Avitar, Inc. | 3.56 Million USD | 17.03% |
| Nanomix Corporation | 8.36 Million USD | 64.607% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 86.401% |
| Theraclion SA | 7.43 Million USD | 60.192% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | -194.02% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 4.785% |
| Lombard Medical, Inc. | 30.29 Million USD | 90.222% |
| ALR Technologies Inc. | 6.33 Million USD | 53.257% |
| Stratec SE | 46.32 Million USD | 93.606% |
| Vycor Medical, Inc. | 1.27 Million USD | -132.199% |
| Heart Tronics, Inc. | 14.46 Million USD | 79.519% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.717% |
| VMS Rehab Systems, Inc. | 63.63 USD | -4654336.587% |
| NewCardio, Inc. | 9.56 Million USD | 69.035% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 15.213% |
| Ingen Technologies, Inc. | 1.88 Million USD | -57.347% |
| Odyssey Group International, Inc. | -14.26 Million USD | 120.767% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -580.05% |
| Wellness Center USA, Inc. | 1.29 Million USD | -128.771% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 79.071% |
| IR-Med Inc. | 4.89 Million USD | 39.485% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1334.76% |
| Polarean Imaging plc | 12.24 Million USD | 75.809% |
| United American Healthcare Corporation | 59 Thousand USD | -4919.692% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -626.804% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -2357.244% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -366.626% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -74.669% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -124.281% |
| Urologix, Inc. | 10.09 Million USD | 70.654% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -134.429% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 50.211% |
| SS Innovations International, Inc. | 21.38 Million USD | 86.149% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -1186.312% |
| Smith & Nephew plc | 3.46 Billion USD | 99.915% |
| NIOX Group Plc | 22.27 Million USD | 86.706% |
| Fuse Medical, Inc. | 10.35 Million USD | 71.385% |
| Broncus Holding Corporation | 38.15 Million USD | 92.237% |
| Brain Scientific Inc. | 9.66 Million USD | 69.35% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 71.255% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -4779.268% |